PDS Biotechnology PDSB 深 滬
等待開盤 11-04 09:30:00 美东时间
1.41
+0.040
+2.92%
華盛通- 最 高1.53
- 今 開1.35
- 成交量 516.76万股
- 最 低 1.35
- 昨 收 1.37
- 總市值 1.02亿
- 52周最高 1.79
- 市盈率 靜 --
- 換手率 7.13%
- 52周最低 0.1952
- 委 比 35.98%
- 總股本 7247.42万
- 歷史最高 17.85
- 量 比 0.59
- 振 幅 13.14%
- 歷史最低 0.1952
- 每 手 1
- 風險率 0.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅1112.12%！Canaccord Genuity上调Wave Life Sciences目标价至44美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences"买入"评级，目标价从42美元升至44美元；Canaccord Genuity：维持Pharming Group"买入"评级，目标价从38美元升至41美元
10-30 12:30
B. Riley Securities Reiterates Buy on PDS Biotechnology, Raises Price Target to $4
B. Riley Securities analyst Mayank Mamtani reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and raises the price target from $3 to $4.
10-30 01:11
PDS Biotechnology highlights oncology pipeline and PDS0301 progress
PDS Biotechnology ( ($PDSB) ) has issued an announcement. On October 20, 2026, ...
10-21 18:29
PDS Biotechnology Reshapes Board with New Director Appointments
The latest update is out from PDS Biotechnology ( ($PDSB) ). On October 18, 202...
10-20 20:28
PDS Biotechnology Highlights PDS0301 Data in KOL Event
An announcement from PDS Biotechnology ( ($PDSB) ) is now available. On October...
10-06 20:29
PDS Biotech highlights strong Phase 2 PDS0101 results
PDS Biotechnology ( ($PDSB) ) has shared an announcement. On September 22, 2026...
09-22 20:51
PDS Biotechnology Announces Publication Of Results From Phase 2 Trial Evaluating PDS0101, HPV16-Targeted Immunotherapy, In Combination With Pembrolizumab In JAMA Oncology, Peer Reviewed Journal Of American Medical Association
39.3 months median overall survival in first-line (1L) R/M immune checkpoint inhibitor naïve patients Company continues to prioritize PDS0301 in metastatic colorectal cancer (mCRC) while pursuing partnership strategy for PDS0101 PRINCETON, N.J., Sept. 22, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology C...
09-22 20:08
PDS Biotechnology Highlights Progress in Colorectal Cancer Programs
PDS Biotechnology ( ($PDSB) ) just unveiled an announcement. PDS Biotechnology ...
09-22 04:59
PDS Biotech Stock Surges Tuesday: What's Driving the Action?
Shares of PDS Biotechnology Corp (NASDAQ:PDSB) are trading sharply higher Tuesday afternoon, extending Monday’s gains as investors continue to react to the closing of a multi-tranche financing agreement. PDS Biotechnology shares are powering higher. Why is PDSB stock up today? Dr. Soon-Shiong’s Inve...
09-16 02:12
美股大行评级 | 多家大行齐上调Robinhood目标价！最高看至150美元；安进股价大跌后评级遭下调
今日重点评级关注：Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.3美元升至8.45美元；摩根大通：维持Vera Therapeutics"超配"评级，目标价从76美元升至83美元
09-09 15:36
